Illumina, Inc. is a U.S. life science company that develops next-generation sequencing (NGS) and microarray technologies used in genomics research and clinical research. It sells sequencing instruments and consumables, array systems and BeadChips, and informatics software for run management, secondary analysis and cloud workflows.

Platforms and assays

Illumina’s sequencing portfolio spans production and benchtop systems (e.g., NovaSeq X Series, NextSeq 1000/2000, MiSeq i100 Series, iSeq 100) plus flow cells and reagent kits. Its assays include library prep and targeted panels such as Illumina DNA Prep, Illumina RNA Prep with Enrichment, Nextera XT, TruSeq RNA Library Prep v2, and TruSight Oncology 500 (incl. ctDNA).

Arrays and informatics

Microarray offerings include Infinium BeadChips (Global Screening Array, MethylationEPIC v2.0) and the iScan scanner. Informatics includes DRAGEN secondary analysis, BaseSpace Sequence Hub, and Illumina Connected Analytics for secure cloud analysis and workflow development.